| BICYCLE THERAPEUTICS ADR |
| USA |
| Gesundheit |
| US0887861088 / A2PKZC |
| 50BA (Frankfurt) / BCYC (NASDAQ) |
| FRA:50BA, ETR:50BA, 50BA:GR, NASDAQ:BCYC |
| - |
| https://www.bicycletherap.. |
|
Bicycle Therapeutics plc is a biopharmaceutical company developing precision-guided therapeutics to treat solid tumors. The company specializes in bicyclic peptides, a novel class of fully synthetic, chemically-derived medicines formed by constrainin..
>Volltext.. |
| 290.49 Mio. EUR |
| -232.87 Mio. EUR |
| 62.1 Mio. EUR |
| -237.41 Mio. EUR |
| -188.21 Mio. EUR |
| -2.72 EUR |
| 15 Mio. EUR |
| 538.37 Mio. EUR |
| -214.32 Mio. EUR |
| 11.03 |
| 105.62% |
| -29.97% |
| - |
| - |
| - |
| - |
| BICYCLE THERAPEUTICS, BICYCLE THERAPEUTIC |
| 08.04.26 |